Specialties News Desk About Research Staff Blog Find A Provider Find A Location Patient Resources Bill Pay Careers UROLOGY SPECIALTIES, CONDITIONS, TREATMENTS & TECHNOLOGY Urologic Oncology (Cancer) Urologic Oncology is a subspecialty of Urology. Cancer can develop in any organ of the urinary system and the male reproductive system. As with other forms of cancer, the earlier a urological cancer is detected, the greater the chance of successful treatment, that is, removing it before it becomes aggressive and spreads. Not all abnormal masses of cells are cancerous. A biopsy -by removing a small sample of tissue so the cells can be examined with a microscope will determine if a tumor is cancerous (malignant) or non-cancerous (benign). It’s important to know the symptoms of urological cancer and see your doctor as soon as possible if you have any of them. Of course, most symptoms have several possible causes. Only a medical examination can determine if the actual cause is cancer or another condition. Seeing your doctor can ease your fears. The Michigan Institute of Urology is committed to providing outstanding care by offering the latest and most effective therapies in a compassionate setting. Patient Information for Urologic Oncology Thousands of men and women are diagnosed each year with cancer of the bladder, kidney and the prostate. New breakthroughs in cancer care, treatment options and ongoing research for potential cures of urologic malignancies give new hope for patients from all walks of life. We have provided you with a wealth of information on Urologic Oncology conditions, treatments and technology below. To learn more about your office visit, what to expect and what to bring to your appointment please click here. Prostate Cancer Therapeutics Xtandi – Enzalutamide Zytiga – Abiratirone Associated Treatments: Observation / Active Surveillance Laparoscopic Robotic Prostatectomy Radical Retropubic Prostatectomy Radiation Therapy Radiation Therapy-Intensity Modulated Radiation Therapy (IMRT) Intravesical Chemotherapy (BCG, Mitomicin C) Partial Cystectomy (Robotic,Laparoscopic, or Open) Urinary Diversions (Ileal Conduit or Neobladder) Partial Nephrectomy (Robotic, Laparoscopic, or Open) Cryotherapy (Robotic, Laparoscopic, or Open) Distal Ureterectomy (Robotic,Laparoscopic, or Open) Adrenalectomy (Robotic, Laparoscopic, or Open) Retroperitoneal Lymph Node Dissection Partial Penectomy MOHS Surgery Chemotherapy Valstar (Valrubicin) Radical Prostatectomy Radical Perineal Prostatectomy Targeted Cryotherapy of the Prostate Radiation Therapy-Brachytherapy High Dose Rate / Low Dose Rate Endoscopic Resection of the Bladder Tumor Radical Cystectomy (Robotic,Laparoscopic, or Open) Radical Nephrectomy (Robotic,Laparoscopic, or Open) Nephroureterectomy (Robotic, Laparoscopic, or Open) Radiofrequency Ablation (Robotic,Laparoscopic, or Open) Laser Ablation of Ureteral Tumor Radical Orchiectomy Systemic Chemotherapy Total Penectomy Laser Therapy Medications Associated Technologies: Cryoablation Cryotherapy Lasers DaVinci Robotic Surgery Radiofrequency Ablation Bladder Cancer Screening and Surveillance with FISH , cytology, and NMP-22 Associated Conditions: Prostate Cancer Bladder Cancer Kidney Cancer Urethral Cancer Adrenal Tumors Testicular Cancer Penile Cancer BACK © Michigan Institute of Urology, P.C. Disclaimer, Privacy & Terms of Use News Desk Careers Research History Staff UC